Leukemia, Myelodysplasia, Transplantation

MD IQ

Conference Coverage

TKI discontinuation appears safe in CML

NEW YORK – Evidence mounts for safe discontinuation of tyrosine kinase inhibitor treatment in patients with...

Conference Coverage

Venetoclax promising in unfit elderly AML patients

NEW YORK – Physicians are watching data on venetoclax, which has the potential to treat a subset of patients who can’t tolerate intensive therapy...

Pages